ELAN

12.25

1.84% -0.23

After Hours: 12.25

Elanco Animal Health Inc (ELAN)

Overview News Price History Option Chain Financials Discussions Forecast

Elanco Animal Health Inc stock is traded at $12.25, with a volume of 5.47M. It is down -1.84% in the last 24 hours and down -2.47% over the past month.

Previous Close:

$12.48

Open:

$12.5

24h Volume:

5.47M

Relative Volume:

1.21

Market Cap:

$6.06B

Revenue:

$4.49B

Net Income/Loss:

$-1.26B

P/E Ratio:

-61.25

EPS:

-0.2

Net Cash Flow:

$425.00M

1W Performance:

-6.70%

1M Performance:

-2.47%

6M Performance:

-32.69%

1Y Performance:

-4.52%

1-Day Range:

$12.23

$12.53

1-Week Range:

$12.23

$13.48

52-Week Range:

$11.40

$18.80

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name

Elanco Animal Health Inc

Sector

Healthcare (1194)

Industry

Drug Manufacturers - Specialty & Generic (88)

Phone

877-352-6261

Address

2500 INNOVATION WAY, GREENFIELD

Employee

Twitter

@Elanco

Next Earnings Date

2024-11-07

Latest SEC Filings

ELAN's Discussions on Twitter

Compare ELAN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELAN Elanco Animal Health Inc	12.25	6.06B	4.49B	-1.26B	425.00M	0.40
ZTS Zoetis Inc	175.32	79.10B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.69	43.81B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.67	43.34B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	17.80	20.17B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	13.04	15.56B	15.05B	-883.30M	1.89B	-0.74

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-24	Initiated	Leerink Partners	Market Perform
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-24	Upgrade	Stifel	Hold → Buy
Dec-19-23	Initiated	Jefferies	Buy
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-07-23	Initiated	Exane BNP Paribas	Outperform
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral
Jul-21-22	Downgrade	Goldman	Buy → Sell
Jul-12-22	Initiated	Piper Sandler	Neutral
Nov-18-21	Initiated	Morgan Stanley	Overweight
Oct-28-21	Downgrade	Stifel	Buy → Hold
Aug-05-21	Resumed	Credit Suisse	Outperform
Jun-15-21	Upgrade	Cleveland Research	Underperform → Neutral
May-11-21	Upgrade	Barclays	Underweight → Equal Weight
May-11-21	Upgrade	Gabelli & Co	Hold → Buy
Apr-15-21	Initiated	Stifel	Buy
Mar-22-21	Downgrade	Gabelli & Co	Buy → Hold
Feb-26-21	Upgrade	Credit Suisse	Neutral → Outperform
Dec-09-20	Downgrade	Argus	Buy → Hold
Nov-09-20	Downgrade	Barclays	Overweight → Underweight
Aug-20-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-13-20	Resumed	Credit Suisse	Neutral
Aug-04-20	Resumed	Goldman	Buy
Jul-27-20	Downgrade	Cleveland Research	Neutral → Underperform
Apr-02-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-10-20	Initiated	Raymond James	Mkt Perform
Dec-19-19	Upgrade	BofA/Merrill	Neutral → Buy
Nov-07-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-23-19	Initiated	Barclays	Overweight
Aug-26-19	Downgrade	BofA/Merrill	Buy → Neutral
Aug-15-19	Upgrade	UBS	Sell → Neutral
May-23-19	Initiated	Guggenheim	Neutral
Mar-18-19	Upgrade	BofA/Merrill	Neutral → Buy
Mar-13-19	Resumed	Morgan Stanley	Equal-Weight
Feb-12-19	Initiated	William Blair	Mkt Perform
Jan-23-19	Initiated	UBS	Sell
Jan-15-19	Initiated	Argus	Buy
Oct-15-18	Initiated	Morgan Stanley	Equal-Weight

View All

Elanco Animal Health Inc Stock (ELAN) Latest News

09:03 AM

ELAN DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important December 6 Deadline in Securities Class Action – ELAN - GlobeNewswire Inc.

09:03 AM

02:21 AM

US FDA approves Elanco's treatment for parasitic infections in dogs - AOL

02:21 AM

09:40 AM